In a striking move that underscores the growing emphasis on domestic manufacturing in the biopharmaceutical sector, Amgen, a titan in the American biotech landscape, has committed a substantial $650 million to expand its biologics facility in Juncos, Puerto Rico. This investment is not merely a
Lipid reprogramming has emerged as a critical frontier in understanding and treating clear cell renal cell carcinoma (ccRCC), the predominant subtype of kidney cancer that accounts for a significant portion of cases worldwide. This metabolic transformation, where tumor cells drastically alter how
The spinner flask market is emerging as a cornerstone of laboratory equipment, particularly within the realm of cell culture technologies, as it addresses the growing needs of biotechnology and pharmaceutical sectors. These specialized vessels, engineered to cultivate cell cultures under
I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with extensive experience in technology, innovation, and research and development within the industry. Today, we’re diving into the exciting world of biomanufacturing, focusing on a groundbreaking new lab at a prominent
In a stunning revelation that has sent ripples through the medical community, a recent study published in The New England Journal of Medicine has uncovered a direct link between a widespread skin virus and the development of a common form of skin cancer. The research spotlights betapapillomavirus
In a world where genetic diseases like neuromuscular disorders have long defied effective treatment, a staggering statistic emerges: over 7,000 rare diseases affect millions globally, with many lacking viable therapies, spurring a transformative wave in biopharmaceutical innovation. This wave is
